Sridharan R, Gonzales-Cope M, Chronis C, Bonora G, McKee R, Huang C, Patel S, Lopez D, Mishra N, Pellegrini M, Carey M, Garcia BA, Plath K. Proteomic and genomic approaches reveal critical functions of H3K9 methylation and heterochromatin protein-1 gamma in reprogramming to pluripotency
. Nat Cell Biol. 2013;15(7):872-882.
Rong S, Cao Q, Liu M, Seo J, Jia L, Boudyguina E, Gebre AK, Colvin PL, Smith TL, Murphy RC, Mishra N, Parks JS. Macrophage 12/15 lipoxygenase expression increases plasma and hepatic lipid levels and exacerbates atherosclerosis
. J Lipid Res. 2012;53(4):686-695.
Kalin Y, Qiang C, Reilly CM, Cann JA, Rhonda BD, Olson EN, Garcia B, Mishra NA. An epigenetic switch involving chromatin modifier HDAC9 in T cells links to lupus pathogenesis in MRL/Ipr mice [abstract]. J Dermatol. 2010;37(Suppl 1):35.
Furie R, Stohl W, Ginzler EM, Becker M, Mishra N, Chatham W, Merrill JT, Weinstein A, McCune WJ, Zhong J, et al. Biologic activity and safety of belimumab, a neutralizing anti-B-lymphocyte stimulator (BLyS) monoclonal antibody: a phase I trial in patients with systemic lupus erythematosus
. Arthritis Res Ther. 2009;10(5):art. R109.
Burger KL, Mishra N, Seals D. Tks5 and macrophage podosome formation [abstract]. Clin Exp Metastasis. 2009;26(7):869.
Mishra N, Hammer G, inventors; Wake Forest University Health Sciences, assignee. Method of treating immune diseases. United States patent US 7,557,141. 2009 July 7. 2009;():.
Lu X, Kovalev GI, Chang H, Kallin E, Knudsen G, Xia L, Mishra N, Ruiz P, Li E, Su L, Zhang Y. Inactivation of NuRD component Mta2 causes abnormal T cell activation and lupus-like autoimmune disease in mice
. J Biol Chem. 2008;283(20):13825-33.
Zhu X, Lee J-Y, Timmins JM, Brown JM, Boudyguina E, Mulya A, Gebre AK, Willingham MC, Mishra N, Parks JS, et al. Increased cellular free cholesterol in macrophage-specific Abca1 knock-out mice enhances pro-inflammatory response of macrophages
. J Biol Chem. 2008;283(34):22930-41.
Sodhi R, Mishra N. Selective toll-like receptor agonist combinations synergistically trigger inflammatory mediators in macrophages, which can be inhibited by histone deacetylase inhibition [abstract]. Arthritis Rheum. 2008;58(9 Suppl):S185.
Garcia BA, Hake SB, Diaz RL, Kauer M, Morris SA, Recht J, Shabanowitz J, Mishra N, Strahl BD, Allis CD, Hunt DF. Organismal differences in post-translational modifications in histones H3 and H4
. J Biol Chem. 2007;282(10):7641-7655.
Kammer GD, Mishra N, inventors; Wake Forest University Health Sciences, assignee. Method of treating autoimmune disease. United States patent US 7,271,198. 2007 Sept 18. 2007;():.
Atwood T, Carter C, Zhu JM, Mishra N. Monitoring neuropsychiatric symptoms in Mrl/lpr lupus mouse model with proton magnetic resonance spectroscope [abstract]. Arthritis Rheum. 2006;54(9):S622.
Mishra N, Keiger K, Labourier E. MicroRNA signature in human lupus [abstract]. Arthritis Rheum. 2006;54(9 Suppl):S753.
Mishra N, Keiger K, Labourier E. Microrna, innate immunity and lupus [abstract]. Arthritis Rheum. 2006;54(9 Suppl):S39.
Mishra N, Parks J, Rankin C, Clair R. Histone deacetylase inhibitors decrease macrophage foam cell formation and stabilize atherosclerotic plaques by multiple mechanisms [abstract]. Arthritis Rheum. 2006;54(9 Suppl):S580.
Snowhite I, Mishra N. Histone hypermethylation is an indicator of epigenetic plasticity in activated B lymphocytes [abstract]. Arthritis Rheum. 2006;54(9 Suppl):S41.
Snowhite I, Mishra N. Histone hypermethylation is an indicator of epigenetic plasticity in activated B lymphocytes [abstract]. Arthritis Rheum. 2006;54(9 Suppl):S69.
Sodhi R, Mishra N. Selective toll-like receptor agonist combinations synergistically trigger inflammatory mediators in macrophages, which can be inhibited by histone deacetylase inhibition [abstract]. Arthritis Rheum. 2006;54(9 Suppl):S43.
Sodhi R, Mishra N. Selective toll-like receptor agonist combinations synergistically trigger inflammatory mediators in macrophages, which can be inhibited by histone deacetylase inhibition [abstract]. Arthritis Rheum. 2006;54(9 Suppl):S635.
For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.
For a list of earlier publications, visit the Carpenter Library Publication Search.
The overall Patient Rating score is the average of responses to the nine questions listed below. The questions are from the Press Ganey Patient Satisfaction Survey. Responses are measured on a 1 to 5 scale, where 1 represents "very poor" and 5 represents "very good."
Comments are taken from the Care Provider section of the Press Ganey Patient Satisfaction Survey. Comments are posted exactly as they are written. Comments are added weekly. To protect patient privacy and confidentiality, patient names are not included.
he completely dismissed my concerns without even a discussion or thorough exam. he even went as far as suggesting that the condition my mother has lived with for 30 years was not real -- and he's never met her. I'll never go back.
Experience is good.
Excellent care. Very thorough. Answered all of my questions. Really appreciated Dr. Mishra's time.
I needed to know more about Vasculitis, and what to avoid, etc., would be helpful.
took over two weeks to get an appointment when in severe pain. At the appointment I felt as if the doctor didn't really listen to me or didn't understand my concerns (or didn't care).
I had an excellent experience with Dr. Mishra and his office staff. He is the first doctor to take time and listen to me since I have been sick and I am so grateful. He ordered many labs for me to check for all my symptoms. I have received my lab results but have not scheduled a follow up or anything as of yet. Overall he has helped me more than he will probably ever realize and I am so thankful. Also the office staff from registration all the way to the lab staff that saw me for blood work were so pleasant and kind. Thank you all so much.
*Dr. Mishra is a very good doctor!
After getting the results in professional jargon that I didn't understand, I e-mailed Dr Mishra and he promptly replied in terms I could understand.
*Dr. Mishra repeats my questions/concerns back to me but never actually answers them.
I have only seen this care provider for 3 visits and it is also the first time using Wake Med as a provider. I have been extremely pleased with the care I have received. Dr. Mishra has help me more in 3 visits than my former provider( not associated with this facility) did in 12 months. I have great trust in Dr. Mishra and am looking forward better health.
A lot of test were ran. But my next visit was schedule out 4 months out. I had question about the results and he was very quick to respond with answers & responded with a new appoint the next week.
*Dr. Mishra hasn't told me very much about the med I'm on. He hasn't told me much about follow-up care or care at home.
Dr. Mishra is excellent.